Skip to content

The C-reactive protein-triglyceride-glucose index and its obesity-derived indicators predict cardio-renal-metabolic multimorbidity: evidence from the UK biobank and CHARLS.

Aug 2026 · Diabetes Research and Clinical Practice · Vol 240, pp. 113475 · 0 citations · 49 references
Medicine

TL;DR

CTI-derived obesity-related indices, especially CTI-WC and CTI-WHtR, were associated with CRMM incidence and progression and may improve risk stratification and may improve risk stratification beyond traditional measures.

Abstract

Background

Cardio-renal-metabolic multimorbidity is defined as the coexistence of cardiovascular disease, type 2 diabetes, and chronic kidney disease. We examined the relationships between C-reactive protein-triglyceride glucose-index and its five obesity derivatives with CRMM incidence and progression.

Methods

We included 374,513 participants from UK Biobank and 6,401 participants from CHARLS. Cox, RCS, and multistate models were used to assess incident CRMM and disease transitions. Predictive performance was evaluated using time-dependent ROC, C-index, NRI, and IDI.

Results

Over 15.98 years of follow-up, 13,315 participants developed CRMM.six indices were positively associated with CRMM risk in UK Biobank.CTI-WC showing the strongest association (HR 1.974, 95% CI 1.943-2.007), followed by CTI-WHtR (HR 1.919, 95% CI 1.890-1.950). Multistate analyses also supported associations with CRMM progression, particularly for transitions from healthy to FCRMD, again strongest for CTI-WC (HR 1.538, 95% CI 1.526-1.550). Adding CTI-derived indices improved prediction, with NRI ranging from 21.161% to 23.929%, IDI from 1.051% to 1.512%, and ΔC-index from 0.029 to 0.038 , suggesting improved risk stratification beyond traditional measures. In CHARLS, associations were directionally consistent but attenuated,likely due to the smaller validation cohort.

Conclusions

CTI-derived obesity-related indices, especially CTI-WC and CTI-WHtR, were associated with CRMM incidence and progression and may improve risk stratification.

View source

Similar papers

Open access Aug 2026

Composite C-reactive protein-triglyceride-glucose adiposity indices and incident cardiovascular-liver-metabolic multimorbidity: a prospective cohort study

The C-reactive protein-triglyceride-glucose index (CTI) is a comprehensive marker that reflects inflammation and insulin resistance. Cardiovascular-liver-metabolic (CLM) diseases caused by multiple factors may be related to insulin resistance, obesity, metabolism, etc. Our aim is to explore the association between the...

Jing Chen, Zhong-Hua Sun, Jia-Jun Qiu et al. · 1 citation
Review Open access Sep 2026

C-Reactive Protein-Triglyceride-Glucose Index, Inflammatory-Metabolic Burden, and Prevalent Stroke in U.S. Adults: NHANES 1999-2010

Background The C-reactive protein-triglyceride-glucose index (CTI) integrates inflammatory and metabolic markers, but recent studies have already linked CTI to stroke and cardiovascular outcomes. Whether CTI provides information beyond established risk factors in the U.S. general population remains uncertain. Methods W...

Q. Deng, Z. Yin · 0 citations
Review Aug 2026

Associations of C-reactive protein-triglyceride glucose-related indices with mortality across glycemic states: a nationwide prospective cohort study.

BACKGROUND The associations and comparative discrimination of indices integrating inflammation, insulin resistance, and body shape within glycemic-status strata remain uncertain. METHODS We included 13,867 adults from the 1999-2010 and 2015-2018 National Health and Nutrition Examination Survey. Complex-survey weighte...

Junqi Liao, Jie Yang, Yuanjiang Zhao et al. · 0 citations
Open access Aug 2026

The cholesterol, high-density lipoprotein, and glucose index and its derived indices predict cardiometabolic multimorbidity development and progression in metabolic dysfunction-associated steatotic liver disease individuals: a prospective cohort study

Among individuals with MASLD, CHG-related indices, particularly CHG-WHtR and CHG-WC, were associated with incident CMM and transition-specific disease progression and improved risk prediction, and readily available indices may help refine CMM risk stratification in MASLD.

K. Mu, Jing Zhang, Shuang Liang et al. · 0 citations
Open access Oct 2026

Association of the C-Reactive Protein–Triglyceride–Glucose Index with Kidney Injury in Patients with Coronary Heart Disease: A Two-Center Cross-Sectional Study

Background The composite index of inflammation and insulin resistance (IR), the C-reactive protein (CRP)–triglyceride–glucose (TyG) index (CTI), has been suggested to be closely associated with cardiovascular disease. However, the relationship between the CTI and kidney injury (KI), including its subtypes [declined kid...

Meng-Meng Fan, Xue-Ping Zhang, Xian-Wei Tian et al. · 0 citations
Open access Sep 2026

Association of C-reactive protein-triglycerides-glucose index-waist-to-height ratio with mortality in metabolic dysfunction-associated steatotic liver disease (MASLD): evidence from two cohort studies

The positive association between CTI-WHtR and mortality risk in the MASLD population was robust in both cohorts, but its independent discriminatory performance was generally weak, and its relative discriminatory performance varied across populations, lacking a stable cross-population advantage.

Guang-Jie Tu, Hang Zhai, Jun-Ming Xu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.